{"References": [{"title": "Engineering antibodies for enhanced function", "authors": "Davies, G. W., Romain, E., and Holliger, P.", "journal": "Nature Reviews Immunology", "year": "2019", "volumes": "19", "first page": "457", "last page": "472", "DOI": "10.1038/s41577-019-0179-0"}, {"title": "Bispecific antibodies for cancer immunotherapy", "authors": "Shan, L., Wang, Y., and Wu, L.", "journal": "Cancer Letters", "year": "2018", "volumes": "421", "first page": "128", "last page": "136", "DOI": "10.1016/j.canlet.2018.02.015"}, {"title": "Fc engineering of therapeutic antibodies: the impact on their effector functions", "authors": "Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., and Weikert, S. H.", "journal": "Journal of Immunology", "year": "2001", "volumes": "166", "first page": "4379", "last page": "4385", "DOI": "10.4049/jimmunol.166.8.4379"}, {"title": "Antibody–drug conjugates: preclinical and clinical development", "authors": "Polson, A. G., and Lambert, J. M.", "journal": "Frontiers in Bioscience", "year": "2013", "volumes": "18", "first page": "1084", "last page": "1103", "DOI": "10.2741/4145"}, {"title": "Passive immunization for the prevention and treatment of viral infections", "authors": "Plotkin, S. A.", "journal": "Vaccine", "year": "2014", "volumes": "32", "first page": "3905", "last page": "3909", "DOI": "10.1016/j.vaccine.2014.05.051"}, {"title": "Antibody engineering to enhance therapeutic function", "authors": "Wu, H., and Saphire, E. O.", "journal": "Nature Reviews Drug Discovery", "year": "2017", "volumes": "16", "first page": "440", "last page": "456", "DOI": "10.1038/nrd.2017.101"}, {"title": "Fc engineering of therapeutic antibodies to improve their effector functions", "authors": "Shields, R. L., and Lai, J.", "journal": "Current Opinion in Biotechnology", "year": "2003", "volumes": "14", "first page": "424", "last page": "430", "DOI": "10.1016/j.copbio.2003.08.004"}, {"title": "Bispecific antibodies: a mechanistic review of the pipeline", "authors": "Kontermann, R. E., and Brinkmann, U.", "journal": "Nature Reviews Drug Discovery", "year": "2015", "volumes": "14", "first page": "413", "last page": "433", "DOI": "10.1038/nrd4558"}, {"title": "Antibody–drug conjugates: a new class of anticancer agents", "authors": "Chari, R. V. J., Okeley, N. M., and Senter, P. D.", "journal": "Nature Reviews Cancer", "year": "2014", "volumes": "14", "first page": "760", "last page": "774", "DOI": "10.1038/nrc3817"}, {"title": "Strategies for circumventing pathogen immune evasion mechanisms", "authors": "Coban, C., Ishii, K. J., and Klinman, D. M.", "journal": "Expert Review of Vaccines", "year": "2007", "volumes": "6", "first page": "451", "last page": "460", "DOI": "10.1586/14760584.6.4.451"}]}